3D Breast Biopsy Technology allows patients to have breast lesions identified on their mammogram biopsied with the precision of 3D stereotactic localization. 3D stereotactic localization is a low risk, minimally invasive technique used to biopsy for detection of breast cancer rather than undergoing an excisional biopsy procedure that requires an operating room visit and anesthesia. The 3D stereotactic localization of breast lesions allows for a small number of samples to be taken from the breast and benefits the patient by conserving breast tissue. It is also more convenient, efficient and cost effective for the patient as lumpectomy is only performed when malignancy is confirmed through the 3D biopsy.
“The clinical implications of this technology are profound. Pairing our existing 3-D mammography with advanced 3-D biopsy capabilities will enable far more precise location and sampling of tissue, minimizing the impact on surrounding tissue and yielding a better outcome for our patients.” – Rakel Astorga, M.D.